Proof-of-concept study holds promise for safer gene therapy techniques for treating immunodeficiencies Post author: Post published:November 1, 2023 Post category:uncategorized Researchers described an approach to edit the recombination-activating gene 2 (RAG2) locus for therapeutic applications. You Might Also Like Understanding antimicrobial resistance in hospital-acquired pneumonia January 18, 2024 Understanding how the hippocampus discriminates social threat from safety October 15, 2024 Baylor study sheds light on role of CDKL1 and CDKL2 in neurodevelopmental disorders March 15, 2025